Landscape Capital Management L.L.C. Takes Position in The Chemours Company (NYSE:CC)

Landscape Capital Management L.L.C. acquired a new stake in shares of The Chemours Company (NYSE:CC) during the third quarter, Holdings Channel reports. The fund acquired 10,195 shares of the specialty chemicals company’s stock, valued at approximately $207,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of CC. Matrix Trust Co purchased a new stake in shares of Chemours during the third quarter worth about $25,000. Blue Trust Inc. boosted its holdings in shares of Chemours by 166.9% during the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 731 shares during the period. New Covenant Trust Company N.A. purchased a new stake in shares of Chemours during the first quarter worth about $29,000. Signaturefd LLC boosted its holdings in shares of Chemours by 163.7% during the third quarter. Signaturefd LLC now owns 1,959 shares of the specialty chemicals company’s stock worth $40,000 after purchasing an additional 1,216 shares during the period. Finally, Itau Unibanco Holding S.A. purchased a new stake in shares of Chemours during the second quarter worth about $58,000. 76.26% of the stock is owned by institutional investors.

Insider Activity

In other news, SVP Alvenia Scarborough sold 7,500 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $20.64, for a total value of $154,800.00. Following the completion of the transaction, the senior vice president now owns 16,645 shares in the company, valued at $343,552.80. The trade was a 31.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.47% of the company’s stock.

Analyst Ratings Changes

CC has been the subject of a number of analyst reports. UBS Group dropped their target price on shares of Chemours from $30.00 to $28.00 and set a “buy” rating for the company in a report on Tuesday, August 6th. Morgan Stanley lowered their price objective on shares of Chemours from $30.00 to $25.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. JPMorgan Chase & Co. lowered their price objective on shares of Chemours from $25.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. The Goldman Sachs Group lowered their price objective on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating for the company in a report on Tuesday, September 3rd. Finally, Royal Bank of Canada lowered their price objective on shares of Chemours from $28.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, November 6th. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $24.88.

Chemours Price Performance

CC stock opened at $21.94 on Tuesday. The firm has a 50 day moving average price of $19.47 and a 200-day moving average price of $21.44. The Chemours Company has a 52-week low of $15.10 and a 52-week high of $32.70. The firm has a market capitalization of $3.28 billion, a price-to-earnings ratio of 43.88 and a beta of 1.75. The company has a debt-to-equity ratio of 6.05, a quick ratio of 0.92 and a current ratio of 1.73.

Chemours (NYSE:CC) last released its earnings results on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.08. Chemours had a net margin of 1.34% and a return on equity of 29.48%. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period last year, the business earned $0.64 earnings per share. The business’s revenue was up .9% on a year-over-year basis. Equities research analysts forecast that The Chemours Company will post 1.35 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.25 per share. The ex-dividend date is Friday, November 15th. This represents a $1.00 annualized dividend and a dividend yield of 4.56%. Chemours’s payout ratio is 200.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.